• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [19518 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pertussis: aims and strategy
2004     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pertussis
2009     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against pandemic influenza A/H1N1 2009: target groups and prioritisation
1991     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against Haemophilus influenzae type b
2008     Health Council of the Netherlands Gezondheidsraad (GR) Vaccination against cervical cancer
1994     Health Council of the Netherlands Gezondheidsraad (GR) UV radiation from sunlight
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Utilization patterns of disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis: rationale for improving the harmonization of coverage criteria
2003     Israel Center for Technology Assessment in Health Care (ICTAHC) Utilization patterns of CT and MRI in Israel
2020     Canadian Agency for Drugs and Technologies in Health (CADTH) Utilization of innovator biologics and biosimilars for chronic inflammatory diseases in Canada: a provincial perspective
2005     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Utilization of information and communication technology in managing chronic diseases: a systematic review IPE-05/45 (Public report)
2006     Medical Advisory Secretariat (MAS) Utilization of DXA bone mineral densitometry in Ontario: an evidence-based analysis
2005     Institute for Clinical Evaluative Sciences (ICES) Utilization of CT and MRI scanning among cancer patients in Ontario, 1993-2002
2022     Canadian Agency for Drugs and Technologies in Health (CADTH) Utilization of biologic disease-modifying antirheumatic drugs for plaque psoriasis
2015     Andalusian Health Technology Assessment Area (AETSA) Utility of QF_PCR in prenatal diagnosis of fetal aneuploidies
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of pulmonary metastases resection for colorectal cancer
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Utility of MuSK antibodies in patients with myastenia gravis
2008     Agency for Healthcare Research and Quality (AHRQ) Utility of monitoring mycophenolic acid in solid organ transplant patients
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of exome sequencing for diagnosed dismorphic syndromes, with or without intellectual disabilities. Literature review
2002     Agency for Healthcare Research and Quality (AHRQ) Utility of blood pressure monitoring outside of the clinic setting
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2019     NIHR Health Technology Assessment programme Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis
2001     ECRI Uterine fibroid embolization for the treatment of fibroids
2003     Institute for Clinical Systems Improvement (ICSI) Uterine artery embolization for uterine fibroids
2002     Blue Cross Blue Shield Association (BCBS) Uterine artery embolization for treatment of symptomatic uterine fibroids
2005     HAYES, Inc. Uterine artery embolization for treatment of fibroids
2003     HAYES, Inc. Uterine artery embolization for treatment of fibroids
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Uterine artery embolization for the treatment of fibroids
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Uterine artery embolization for the management of uterine fibroids
2009     HAYES, Inc. Uterine artery embolization
2006     Adelaide Health Technology Assessment (AHTA) Uterine artery embolisation for the treatment of symptomatic uterine fibroids
2004     National Institute for Clinical Excellence (NICE) Uterine artery embolisation for the treatment of fibroids
2003     Wessex Institute for Health Research and Development (WIHRD) Uterine artery embolisation for fibroids
2003     National Institute for Clinical Excellence (NICE) Uterine artery embolisation for fibroids
2010     National Institute for Health and Clinical Excellence (NICE) Uterine artery embolisation for fibroids
2005     Agency for Healthcare Research and Quality (AHRQ) Usual care in the management of chronic wounds: a review of the recent literature
2013     NIHR Health Technology Assessment programme Ustekinumab for treating active and progressive psoriatic arthritis
2009     NIHR Health Technology Assessment programme Ustekinumab for the treatment of moderate to severe psoriasis
2017     Agency for Care Effectiveness (ACE) Ustekinumab for the treatment of chronic plaque psoriasis and psoriatic arthritis
2009     National Institute for Health and Clinical Excellence (NICE) Ustekinumab for the treatment of adults with moderate to severe psoriasis
2019     European Network for Health Technology Assessment (EUnetHTA) Ustekinumab for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response with, lost response to or were intolerant to either conventional therapy or a biologic or have medical contraindications to such therapies
2010     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis - second line after disease modifying anti-rheumatic drugs (DMARDs)
2012     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for psoriatic arthritis
2013     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for plaque psoriasis in adolescents
2014     NIHR Horizon Scanning Centre (NIHR HSC) Ustekinumab (Stelara) for Crohn's disease
2016     HAYES, Inc. Ustekinumab (Stelara; Janssen Biotech Inc.) for treatment of psoriatic arthritis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Ustekinumab (Stelara — Janssen Inc.) indication: psoriatic arthritis
2005     Israel Center for Technology Assessment in Health Care (ICTAHC) Using the literature to forecast utilization of emerging technologies (abstract)
2000     NIHR Health Technology Assessment programme Using routine data to complement and enhance the results of randomised controlled trials
2018     Center for Evidence-based Practice (CEP) Using Patient Generated Health Data in an Electronic Health Record
2006     Alberta Heritage Foundation for Medical Research (AHFMR) Using HTA to identify research gaps: a pilot study
2008     Institute of Health Economics (IHE) Using fetal fibronectin to diagnose pre-term labour
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
2005     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system
2007     Quality Improvement Scotland (NHS QIS ) Using data to improve surgical care - the surgical profiles project
2020     NIHR Health Services and Delivery Research programme Using co-production to improve patient carer and staff experiences in health care organizations: a multi-centre, mixed methods evaluation in inpatient stroke units (CREATE)
2015     NIHR Health Services and Delivery Research programme Using clinical practice variations as a method for commissioners and clinicians to identify and prioritise opportunities for disinvestment in health care: a cross-sectional study, systematic reviews and qualitative study
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Using a spectral reflectance technique to measure transcutaneous bilirubin in neonates: a new device
2001     Agency for Healthcare Research and Quality (AHRQ) Uses of epoetin for anemia in oncology
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of video capsule gastrointestinal endoscopy in digestive bleeding of unknown origin
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of varenicline in smoking cessation therapy
2013     Health Quality Ontario (HQO) Usefulness of urinary antigen testing for Legionella in the treatment of community-acquired pneumonia: a rapid review
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of the European Appropriateness Evaluation Protocol (AEP)
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of thalidomide for the management of sarcomas
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of synthetic graft in knee anterior cruciate ligament reconstruction
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of surgical treatments for obesity
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of SPECT in epilepsy
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of SPECT in epilepsy
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of real-time PCR in acute promyelocytic leukemia patient monitoring
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of real-time PCR for the monitoring of chronic myeloid leukemia patient
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of radiofrequency ablation of liver tumors
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of plasminogen activator inhibitor 4G/5G polymorphism testing in recurrent miscarriage
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of pacemakers with managed 'ventricular pacing mode'
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of music therapy in clinical practice
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography for the assessment of liver metastases
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography (MSCT) for coronary disease
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of multislice computed tomography (MSCT) for coronary disease
2007     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of intervertebral disc prostheses for spine diseases
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hydroxyethyl starch (HES) as plasma expander
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hippotherapy
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hip arthroscopy
2008     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of high-intensity focused ultrasound in prostate cancer
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of extracorporeal shock waves in musculoskeletal disorders
2005     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of ceramic prosthesis in total hip replacement
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of ceramic or metal on metal prostheses in total hip replacement
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of bevacizumab in colon cancer patients
2004     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of autologous growth factors in orthopaedic surgery
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of alpha-glucosidase in pompe disease
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of alpha-glucosidase in Pompe disease
2000     Canadian Task Force on Preventive Health Care (CTFPHC) Use of varicella vaccine in healthy populations: systematic review and recommendations
2004     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) Use of ultrasound in antenatal and primary care
2001     Norwegian Knowledge Centre for the Health Services (NOKC) Use of ultrasonography in the primary health care setting
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of topical anesthetics for suturing and circumcisions in pediatric patients: a review of clinical effectiveness and guidelines
2011     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of the VerifyNow point of care test to detect nonresponsiveness to clopidogrel and aspirin
2003     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of the implantable cardiac defibrillator (ICD) at the McGill University Health Centre (MUHC)
2004     Andalusian Health Technology Assessment Area (AETSA) Use of the drug eluting stents - review
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of the Braden Scale for assessing pressure ulcer risk in acute care: clinical evidence and guidelines
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Use of surgical masks in the operating room: a review of the clinical effectiveness and guidelines
2003     Quality Improvement Scotland (NHS QIS ) Use of stents to treat peripheral arterial disease (PAD)
2005     Agency for Healthcare Research and Quality (AHRQ) Use of spirometry for case finding, diagnosis, and management of chronic obstructive pulmonary disease (COPD)
2007     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Use of sorafenib (Nexavar®) for advanced renal cell carcinoma within NHS Wales